Search

Your search keyword '"Reardon, Brendan"' showing total 248 results

Search Constraints

Start Over You searched for: Author "Reardon, Brendan" Remove constraint Author: "Reardon, Brendan"
248 results on '"Reardon, Brendan"'

Search Results

1. Somatic structural variants drive distinct modes of oncogenesis in melanoma

3. Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma

4. Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

6. Comprehensive Characterization of Cancer Driver Genes and Mutations

7. Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology

9. Transverse Faraday-Rotation Gradients Across the Jets of 15 Active Galactic Nuclei

11. Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

12. Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

14. Comprehensive Characterization of Cancer Driver Genes and Mutations

15. Inherited DNA-Repair Defects in Colorectal Cancer

16. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

17. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

18. Global food policy report 2023: Rethinking food crisis responses

19. Abstract 6084: The Osteosarcoma and Leiomyosarcoma Count Me In Projects of the Cancer Moonshot funded PE-CGS Network directly engage patient participants in genomics research

20. Abstract 965: Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma

21. Figure S6 from Discovery and Features of an Alkylating Signature in Colorectal Cancer

22. Data from AACR Project GENIE: Powering Precision Medicine through an International Consortium

23. Table S3 from AACR Project GENIE: Powering Precision Medicine through an International Consortium

24. Data from Discovery and Features of an Alkylating Signature in Colorectal Cancer

25. Data from Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

26. Supplementary Table S3 from Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

27. Supplementary Figures 1-12 from Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

28. Supplementary Data from Discovery and Features of an Alkylating Signature in Colorectal Cancer

29. Supplemental Methods, Supplemental Tables 1-2, Supplemental Figures 1-4 from AACR Project GENIE: Powering Precision Medicine through an International Consortium

30. Supplemental File 1 from AACR Project GENIE: Powering Precision Medicine through an International Consortium

31. Supplemental Figures from Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer

32. Supplemental Table 1 from Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer

33. Supplementary Data from Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer

34. Supplementary Tables from Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma

35. Supplementary Figures and Legends from Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma

36. Supplementary Information from Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma

37. Data from Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma

38. Circulating tumor DNA and homologous recombination deficiency in bone-predominant mCRPC prior to radium-223 therapy.

39. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma

40. Abstract PR005: Features and susceptibility to dietary-induced alkylating damage in colorectal cancer

41. Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma

43. Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid Cancer

45. Identification of cancer driver genes based on nucleotide context

46. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy

48. Discovery and Features of an Alkylating Signature in Colorectal Cancer

49. Identification of cancer driver genes based on nucleotide context

50. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

Catalog

Books, media, physical & digital resources